Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Total Current Liabilities (2016 - 2025)

CorMedix's Total Current Liabilities history spans 13 years, with the latest figure at $174.3 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 414.98% year-over-year to $174.3 million; the TTM value through Dec 2025 reached $174.3 million, up 414.98%, while the annual FY2025 figure was $174.3 million, 414.98% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $174.3 million at CorMedix, up from $133.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $174.3 million in Q4 2025 and bottomed at $3.0 million in Q1 2021.
  • The 5-year median for Total Current Liabilities is $7.4 million (2023), against an average of $26.5 million.
  • The largest annual shift saw Total Current Liabilities crashed 47.46% in 2021 before it skyrocketed 623.14% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $5.3 million in 2021, then increased by 18.07% to $6.3 million in 2022, then increased by 21.55% to $7.7 million in 2023, then surged by 341.15% to $33.8 million in 2024, then skyrocketed by 414.98% to $174.3 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Total Current Liabilities are $174.3 million (Q4 2025), $133.6 million (Q3 2025), and $31.7 million (Q2 2025).